Objective The role of esophageal cardiac glands has not been fully determined. This study was performed to clarify the protective role of esophageal cardiac glands against the development of gastroesophageal reflux disease (GERD). Methods The subjects included 2,656 Japanese individuals who visited our institution for a detailed medical checkup. GERD symptoms were assessed using the Japanese version of the Carlsson-Dent selfadministered questionnaire (QUEST) and an upper gastrointestinal endoscopy examination in each subject. The presence of reflux esophagitis, size of diaphragmatic hiatus, degree of gastric mucosal atrophy and existence of visible esophageal cardiac glands in the distal esophagus, based on the detection of yellowish elevated areas, were determined using endoscopy. Results Esophageal cardiac glands were observed in 355 cases (13.4%). Reflux esophagitis was significantly less frequent in the cases with esophageal cardiac glands than in those without. The esophageal cardiac glands were mainly located on the left-posterior side of the esophageal wall of the distal esophagus. A multiple regression analysis showed that the presence of esophageal cardiac glands was an independent factor for preventing reflux esophagitis. On the other hand, the existence of these glands did not correlate with the presence of GERD symptoms (QUEST score of 6 or more). Conclusion The presence of visible esophageal cardiac glands may have a protective role against the development of reflux esophagitis.
Introduction
Gastroesophageal reflux disease (GERD) is characterized by the presence of esophageal mucosal injury or reflux symptoms caused by abnormal reflux of acidic gastric contents into the esophagus (1) . The esophageal mucosa is protected from injury from acid reflux by several mechanisms, including salivary secretion, esophageal peristalsis and components of the esophageal mucosal protection system, such as the mucous layer on the surface (2-7). The secretion of mucous from esophageal glands is important for protecting the mucosal surface from the pepsin and protease contained in gastric juices. There are two types of secretory glands in the esophagus: superficial glands located in the proper mucosal layer and deep mucous glands located in the submucosa (8) . Superficial mucosal glands are found in limited numbers in the upper esophagus and near the junction with the stomach. Those located in the distal esophagus are tortuous and tubular, lined with cuboidal or columnar epithelial cells, and resemble the cardiac glands of the cardia. Based on this resemblance, superficial mucosal glands in the distal esophagus are called esophageal cardiac glands. These glands are considered to play a protective role against mucosal injury in the lower esophagus caused by reflux of acidic gastric contents.
Esophageal cardiac glands are visualized as yellow elevated areas in the distal esophagus on endoscopy (9, 10) . However, the relationship between these glands and GERD has not been fully determined. We conducted this relatively large-scale study in order to clarify the protective role of esophageal cardiac glands against the development of GERD in Japanese subjects.
Materials and Methods
This study was approved by the ethics committee of Shimane University Faculty of Medicine. Written informed consent was obtained from all enrolled subjects, and the study was performed according to the World Medical Association Declaration of Helsinki.
The subjects included individuals who visited the Health Center of Shimane Environment and Health Public Corporation for a detailed medical checkup between April 2011 and March 2012. A majority of the subjects were socially active, productive and socioeconomically middle class individuals. After obtaining written informed consent for enrollment into the study, a precise medical history was taken. Individuals with a history of gastric surgery were not included in this study. Patients who had taken medications such as proton pump inhibitors, H2 receptor antagonists or prokinetic drugs within the preceding three months were excluded. In addition, those who had received eradication therapy for Helicobacter pylori (H. pylori) infection were excluded, as a relationship between H. pylori infection and the presence of esophageal cardiac glands has been suggested (9) . The body mass index (BMI) and current smoking and drinking (equivalent to over 50 mL of alcohol per day) habits were also noted.
All subjects underwent an upper gastrointestinal endoscopy examination. Prior to the examination, the presence or absence of reflux symptoms was assessed using the Japanese version of the Carlsson-Dent self-administered questionnaire (QUEST) (11) . We defined subjects with a QUEST score of 6 or more as being positive for reflux symptoms, since a cut-off score of 6 has been demonstrated to have higher specificity for the diagnosis of GERD than a score of 4. The endoscopic findings of reflux esophagitis were evaluated using the Los Angeles (LA) classification (12) , and individuals with a grade of A, B, C or D were diagnosed as being positive for reflux esophagitis. The size of the diaphragmatic hiatus was also assessed during endoscopic observation of the stomach and categorized into three groups (<1.0, 1.0-2.0, >2 cm). The degree of gastric mucosal atrophy was evaluated endoscopically using the classification of Kimura and Takemoto, according to which gastric mucosal atrophy was classified into six groups (C1, C2, C3, O1, O2, O3) (13) . It has been shown that gastric mucosal atrophy progresses from stage C1 to O3 in a successive manner, and this classification has been proven to correlate well with histological features (13) . In addition, gastric acid secretion in patients with gastric mucosal atrophy has been demonstrated to decrease successively from stage C1 to O3 (14) . In this study, we defined C1-C2 as mild, C3-O1 as moderate and O2-O3 as severe gastric mucosal atrophy.
The presence of esophageal cardiac glands was determined based on the detection of a visible yellowish elevated area on the proximal side of the gastroesophageal junction (9, 10) , and the distribution of these lesions was assessed by dividing the findings into four grades (grade 0: absence of esophageal cardiac glands, grade 1: 1-5 spots indicating esophageal cardiac glands, grade 2: continuous transversely extending esophageal cardiac glands involving less than 50% of the esophageal circumference, grade 3: continuous transversely extending esophageal cardiac glands involving at least 50% of the esophageal circumference) (Fig. 1) . None of the present subjects had more than five spots indicating esophageal cardiac glands separately existing in the distal esophagus, while those with continuously transversely extending glands (grade 2 and 3) occasionally had a few unconnected esophageal cardiac glands. Esophageal cardiac glands are considered to extend from grade 0 to 3 in a successive manner. The circumferential localization of the esophageal cardiac glands was also investigated. If multiple esophageal cardiac glands were present, their circumferential positions were recorded. In cases involving transversely extending glands, those extending in all directions were counted. In this study, all upper endoscopic examinations were performed by experienced endoscopists (K.H, S.T and K.Y.), and the endoscopic photographs were reviewed by two endoscopists (K.H and K.A.) to determine the existence and location of the esophageal cardiac glands.
The statistical analyses were performed using the chisquared, Kruskal-Wallis and Mann-Whitney U tests. A multiple logistic regression analysis was conducted to calculate the odds ratios. All calculations were carried out using the Stat View 5.0 software program (Abacus Concepts, Berkeley, USA) for Macintosh, and differences of p<0.05 were considered to be statistically significant.
Results
We prospectively enrolled 2,656 subjects (mean age: 51.8±9.2 years, men: 1,835) in this study, and esophageal cardiac glands were endoscopically observed in 355 cases (13.4%). The number of patients with grade 1, 2, and 3 lesions was 258 (9.7%), 47 (1.8%) and 50 (1.9%), respectively. There were no significant differences in regard to age between the grades. Esophageal cardiac glands were more frequently observed in women (17.1% vs. 11.7%). Reflux esophagitis was significantly less frequent in the cases with esophageal cardiac glands than in those without, and no cases of grade 2 or 3 esophageal cardiac glands involved reflux esophagitis. The grade of reflux esophagitis did not differ between the cases with and without esophageal cardiac glands, whereas GERD symptoms showed a tendency to be less frequent in the subjects with esophageal cardiac glands. In addition, the rate of GERD symptoms tended to be lower among the reflux esophagitis patients with esophageal cardiac glands than among those without. Furthermore, the degree of gastric mucosal atrophy was significantly increased in the cases with esophageal cardiac glands ( Table 1) .
The multiple regression analysis was performed by including several factors known to affect the prevalence of reflux esophagitis and GERD symptoms (15) (16) (17) . A male gender, high BMI, large diaphragmatic hiatus and smoking were shown to be significant risk factors for the presence of reflux esophagitis, while the presence of esophageal cardiac glands and gastric mucosal atrophy were found to be independent factors related to its prevention ( Table 2 ). The multiple regression analysis also showed that a high BMI, severe gastric mucosal atrophy, large diaphragmatic hiatus and smoking were significantly correlated with the occurrence of GERD symptoms. The odds ratio for the presence of esophageal cardiac glands in relation to the development of GERD symptoms was 0.909, which was not statistically significant (Table 3) .
We also investigated the circumferential localization of the esophageal cardiac glands in the 355 cases and found that the lesions were mainly located on the left-posterior side of the esophageal wall of the distal esophagus (Fig. 2) . 
Discussion
Esophageal cardiac glands are found in the proper mucosal layer of the distal end of the esophagus, although their origin has not been determined (8) . These lesions have been reported to be more frequently observed endoscopically in patients with H. pylori infection than in those without, and it has been suggested that H. pylori infection-induced carditis stimulates hypertrophic changes in esophageal cardiac glands (9) . The present results also showed that individuals possessing visible esophageal cardiac glands have more severe gastric mucosal atrophy, which is primarily caused by long-term H. pylori infection in Japanese individuals. Therefore, H. pylori infection is considered to correlate with the presence of endoscopically visible esophageal cardiac glands, although the mechanisms underlying the hypertrophic changes observed in esophageal cardiac glands can-not be explained by the present results. However, the role of esophageal cardiac glands, particularly with regard to the occurrence of GERD, has yet to be determined.
In this study, we investigated the relationship between the presence of endoscopically determined esophageal cardiac glands and the incidence of GERD. Our results demonstrated that these lesions play a protective role against esophageal mucosal injury in the distal esophagus. However, they do not inhibit the development of GERD symptoms. Previously, Yagi and co-workers investigated the prevalence of esophageal cardiac glands in patients with erosive esophagitis and nonerosive reflux disease (NERD) (10) and found that the prevalence of esophageal cardiac glands in patients with NERD is significantly higher than that observed in patients with erosive esophagitis. According to the findings of that and the present study, we conclude that esophageal cardiac glands have a protective effect against injury to the squamous epithelium in the distal esophagus caused by the reflux of acidic gastric contents. On the other hand, GERD symptoms were found to occur irrespective of the presence or absence of these lesions in the current study. Esophageal mucosal injury caused by acidic gastric reflux primarily occurs at the distal end of the esophagus. Esophageal cardiac glands also exist in the distal esophagus, and agents secreted from these glands may provide protection against esophageal mucosal injury. However, acidic reflux contents may stimulate the portion of the esophageal mucosa not covered with mucous secreted from esophageal cardiac glands, thus inducing reflux symptoms. In addition, the acid-neutralizing function of esophageal cardiac glands may not be strong enough to prevent the occurrence of GERD symptoms. Furthermore, several other mechanisms may also influence the development of GERD symptoms, as such symptoms have also been reported to be caused by non-acidic and gas reflux, duodenal juice reflux, esophageal hypersensitivity to acid, esophageal wall distension, esophageal motility abnormalities, sustained esophageal contractions, psychological conditions and others (18) (19) (20) (21) (22) (23) (24) .
An interesting observation in this study is that the esophageal cardiac glands were found to be primarily located on the left-posterior side of the esophageal wall, which is opposite the main site of mucosal injury in patients with LAclassification A and B grade reflux esophagitis (25, 26) . The circumferential localization of mucosal injury in cases of A and B grade reflux esophagitis was shown to largely fit the direction of prolonged acid exposure in a study that used a recently developed 8-channel device with radially arrayed pH sensors (27) . Therefore, the direction of esophageal mucosal injury in patients with reflux esophagitis is influenced by the presence of esophageal cardiac glands, which may have an acid-neutralizing function. A future study utilizing circumferential esophageal pH monitoring testing is needed to clarify the acid-neutralizing function of esophageal cardiac glands.
There are several limitations associated with our study. For example, we used endoscopy only to determine the presence of esophageal cardiac glands. Previously, Yagi and coworkers demonstrated that esophageal cardiac glands were histologically observed in the biopsy specimens of 30 of 38 patients with yellowish elevated areas on the most distal squamous epithelium (9) . Although the presence of yellowish elevated areas in the distal esophagus is considered to indicate the existence of esophageal cardiac glands, invisible esophageal cardiac glands may also be present at the distal end of the esophagus, where they may play a protective role against esophageal mucosal injury. On the other hand, some yellowish elevated areas may not be esophageal cardiac glands. Therefore, detailed histological studies of surgically resected esophageal specimens, including comparisons with preoperative endoscopic findings, are required to clarify whether invisible esophageal cardiac glands exist. In addition, we did not investigate the incidence of H. pylori infection in this study. H. pylori infection has repeatedly been demonstrated to cause gastric mucosal atrophy and have a preventive effect against the development of reflux esophagitis (28) (29) (30) (31) (32) . Therefore, there is a possibility that both hypertrophic changes in esophageal cardiac glands and reductions in reflux esophagitis are induced by H. pylori infection. A long-term endoscopy study is thus needed to clarify the conditions under which visible esophageal cardiac glands are formed and develop and to examine the relationship between the expansion of these lesions and the ability to cure esophageal mucosal injury at the distal end of the esophagus.
In conclusion, our findings demonstrate that esophageal cardiac glands may have a protective role against esophageal mucosal injury caused by acidic gastric contents.
The authors state that they have no Conflict of Interest (COI).

